Simran Kaur, Manav Rachna International Institute Of Research And Studies, India

Speaker

Simran Kaur

  • Manav Rachna International Institute Of Research And Studies
  • India

Presentation

Comparison of effectiveness of arthrocentesis versus arthrocentesis followed by Platelet Rich Plasma (PRP) in cases of temporomandibular joint disorders in north Indian population: A randomised controlled trial

  • April 12 -13, 2027
  • Dubai, UAE

Biography

Dr. Simran Kaur is an Oral and Maxillofacial Physician and Radiologist with specialized expertise in temporomandibular joint (TMJ) disorders, orofacial pain, LASER dentistry, and maxillofacial diagnostics. A Gold Medallist in BDS from the prestigious Maulana Azad Institute of Dental Sciences, New Delhi, she went on to pursue her MDS in Oral Medicine and Radiology from I.T.S Dental College, Hospital and Research Centre, Greater Noida. With six years of clinical experience, Dr. Kaur has developed a comprehensive approach to the diagnosis and management of complex oral and maxillofacial conditions. Her areas of expertise include TMJ disorder diagnosis and treatment, management of orofacial pain, arthrocentesis, LASER applications, aesthetic dentistry, and radiology. Her clinical journey includes experience at Maulana Azad Institute of Dental Sciences, Guru Nanak Charitable Dispensary, and Deen Dayal Upadhyay Government Hospital, alongside advanced postgraduate training in Oral Medicine and Radiology. Dr. Kaur brings together clinical experience, evidence-based diagnostic thinking, and a modern perspective on dentistry. She is particularly passionate about advancing awareness and contemporary approaches to TMD, orofacial pain, LASERs, and maxillofacial diagnosis among dental professionals globally.

Abstract

The intricate etiopathogenesis of the temporomandibular disorders (TMDs) presenting varied signs and symptoms make it difficult to propose a standardized treatment protocol. Recent literature suggests an effective role of platelet rich plasma (PRP) injections in both inflammatory and degenerative TMDs. This study was conducted with an aim to compare the effectiveness of arthrocentesis v/s arthrocentesis followed by PRP in TMD patients. A randomized controlled trial in which 20 participants were randomly selected. Following the inclusion and exclusion criteria, the participants were divided into two groups. The first group comprised of 10 patients who underwent arthrocentesis. The second group comprised of another 10 patients who were administered PRP followed by arthrocentesis. The patients were evaluated on the basis of maximum mouth opening, pain scores (VAS), laterotrusive movements and joint sounds. The follow ups were done at 1 week, 3 weeks, 1 month, 3 months and 6 months.Participants in both the groups showed statistically significant improvements with respect to maximum mouth opening and VAS in the six months postoperative period (p<0.05). However, there were no significant improvements with regards to joint sounds and laterotrusive movements (p>0.05). The outcomes of maximum mouth opening and pain scores were better in the second group after six months of follow-ups (p<0.05). Within the limitations of this study, it can be concluded that arthrocentesis followed by platelet rich plasma injection is a better treatment protocol for the management of TMDs.